RGC icon

Regencell Bioscience

4.92 USD
-0.31
5.93%
At close Dec 20, 4:00 PM EST
1 day
-5.93%
5 days
-5.38%
1 month
-13.68%
3 months
-21.78%
6 months
23.00%
Year to date
-44.41%
1 year
-46.70%
5 years
-53.14%
10 years
-53.14%
 

About: Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Employees: 12

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

5,209% more capital invested

Capital invested by funds: $1.89K [Q2] → $100K (+$98.6K) [Q3]

0.13% more ownership

Funds ownership: 0% [Q2] → 0.14% (+0.13%) [Q3]

33% less funds holding

Funds holding: 3 [Q2] → 2 (-1) [Q3]

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Research analyst outlook

We haven’t received any recent analyst ratings for RGC.

Financial journalist opinion

Charts implemented using Lightweight Charts™